In-vitro function of upstream visfatin polymorphisms that are associated with adverse cardiometabolic parameters in obese children

In-vitro function of upstream visfatin polymorphisms that are associated with adverse cardiometabolic parameters in obese children

Bibliographic Details
Main Authors:	Ooi, Delicia Shu Qin, Ong, Siong Gim, Heng, Chew Kiat, Loke, Kah Yin, Lee, Yung Seng
Format:	Online
Language:	English
Published:	BioMed Central 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124300/

Similar Items

Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome
by: Olszanecka-Glinianowicz, Magdalena, et al.
Published: (2012)

The Role of Visfatin in Diabetic Nephropathy
by: Kang, Young Sun, et al.
Published: (2011)

Visfatin/Nampt: An Adipokine with Cardiovascular Impact
by: Romacho, Tania, et al.
Published: (2013)

Visfatin level in patients with colorectal adenoma
by: Fazeli, Mohammad Sadegh, et al.
Published: (2016)

Adipokines Vaspin and Visfatin in Obese Children
by: Salama, Hassan M., et al.
Published: (2015)

Correlations of serum visfatin and metabolisms of glucose and lipid in women with gestational diabetes mellitus
by: Liang, Zhaoxia, et al.
Published: (2015)

Visfatin/PBEF/Nampt: A New Cardiovascular Target?
by: Peiró, Concepción, et al.
Published: (2010)

Visfatin and resistin: Mediators of the pleiotropic effects of incretins?
by: Nakashima, Eitaro
Published: (2012)

Serum Amyloid a Promotes Visfatin Expression in Macrophages
by: Wang, Shixun, et al.
Published: (2016)

Serum and Vitreous Levels of Visfatin in Patients with Diabetic Retinopathy
by: Wang, Yongqiang, et al.
Published: (2014)

Evaluation of Extrusion Technique for Nanosizing Liposomes
by: Ong, Sandy Gim Ming, et al.
Published: (2016)

Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes
by: Ong, Sandy Gim Ming, et al.
Published: (2016)

The prevalence of adverse cardiometabolic responses to exercise training with evidence-based practice is low
by: Dalleck, Lance C, et al.
Published: (2015)

Increased Expression of Visfatin in Monocytes and Macrophages in Male Acute Myocardial Infarction Patients
by: Chiu, Cheng-An, et al.
Published: (2012)

Visfatin and RBP4 gene expression levels in different adipose tissues and insulin resistance
by: Goktas, Zeynep, et al.
Published: (2012)

Effects of Eating Fresh Lean Pork on Cardiometabolic Health Parameters
by: Murphy, Karen J., et al.
Published: (2012)

Effects of a mat pilates program on cardiometabolic parameters in elderly women
by: Marinda, Fourie, et al.
Published: (2013)

Nicotinamide Phosphoribosyltransferase/Visfatin Does Not Catalyze Nicotinamide Mononucleotide Formation in Blood Plasma
by: Hara, Nobumasa, et al.
Published: (2011)

The effect of omega-3 on the serum visfatin concentration in patients with type II diabetes
by: Hajianfar, Hossein, et al.
Published: (2011)

Serum Visfatin Levels, Adiposity and Glucose Metabolism in Obese Adolescents
by: Taşkesen, Derya, et al.
Published: (2012)

Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity
by: AL-Suhaimi, Ebtesam A, et al.
Published: (2013)

Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells
by: Romacho, Tania, et al.
Published: (2013)

Study of visfatin, asp level in obese children and their clinical significance
by: Rui-zhen, LI, et al.
Published: (2013)

Resistin and Visfatin Expression in HCT-116 Colorectal Cancer Cell Line
by: Ghaemmaghami, Sara, et al.
Published: (2013)

Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis
by: Laiguillon, Marie-Charlotte, et al.
Published: (2014)

Elevated Serum Levels of Visfatin in Patients with Henoch-Schönlein Purpura
by: Cao, Na, et al.
Published: (2014)

Evaluation of Adipokines: Apelin, Visfatin, and Resistin in Children with Atopic Dermatitis
by: Machura, Edyta, et al.
Published: (2013)

VISFATIN LEVEL DISTURBANCES IN PERIPHERAL BLOOD OF PATIENTS WITH DIABETIC NEPHROPATHY
by: I.I. Topchii, et al.
Published: (2014-12-01)

No Association between Visfatin Gene Variants and Metabolic Traits in the Newfoundland Population
by: Jennifer L Shea, et al.
Published: (2010-01-01)

Visfatin Serum Levels Predict Mortality in Critically Ill Patients
by: Alexander Koch, et al.
Published: (2018-01-01)

No Association Between Visfatin (NAMPT) Gene Variants and Metabolic Traits in the Newfoundland Population
by: Jennifer L Shea, et al.
Published: (2010-08-01)

Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism
by: Yang, Jing, et al.
Published: (2016)

The cardiovascular impact of visfatin - an inflammation predictor biomarker in metabolic syndrome
by: HOGNOGI, LARISA DIANA MOCAN, et al.
Published: (2016)

Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E–Deficient Mice
by: Li, Bo, et al.
Published: (2016)

Circulating Visfatin in Hypothyroidism Is Associated with Free Thyroid Hormones and Antithyroperoxidase Antibodies
by: Sawicka-Gutaj, Nadia, et al.
Published: (2016)

Relationship between blood peroxidases activity and visfatin levels in metabolic syndrome patients
by: Samsam-Shariat, Seyyed Ziaedin, et al.
Published: (2014)

Effect of Biochanin A on Serum Visfatin Level of Streptozocin-Induced Diabetic Rats
by: Azizi, Reza, et al.
Published: (2014)

Visfatin promotes cell and tumor growth by upregulating Notch1 in breast cancer
by: Park, Hyun-Joo, et al.
Published: (2014)

Adipo/cytokines in atherosclerotic secretomes: increased visfatin levels in unstable carotid plaque
by: Auguet, Teresa, et al.
Published: (2016)

Waist-to-height ratio, waist circumference, and body mass index as indices of cardiometabolic risk among 36,642 Taiwanese adults
by: Li, Wen-Cheng, et al.
Published: (2011)